We confirmed two tumor suppressor genes, suppressor of cytokine signaling 1 (SOCS1) and cyclin-dependent kinase inhibit 1B (CDKN1B), are negatively regulated in expression by both miR-221 and miR-222, which may have potential to be therapeutic targets for basal-like breast cancer treatment. This evidence concerns the gene CDKN1B and breast carcinoma.